166 related articles for article (PubMed ID: 6831630)
1. Synthesis, biological and biochemical properties of new anthracyclines modified in the aminosugar moiety.
Bargiotti A; Casazza AM; Cassinelli G; Di Marco A; Penco S; Pratesi G; Supino R; Zaccara A; Zunino F; Arcamone F
Cancer Chemother Pharmacol; 1983; 10(2):84-9. PubMed ID: 6831630
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl) daunomycinone derivatives modified at C-3' or C-4'.
Takagi Y; Kobayashi N; Chang MS; Lim GJ; Tsuchiya T
Carbohydr Res; 1998 Feb; 307(3-4):217-32. PubMed ID: 9675364
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of antitumor-active 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
Ok K; Takagi Y; Tsuchiya T; Umezawa S; Umezawa H
Carbohydr Res; 1987 Nov; 169():69-81. PubMed ID: 3427590
[TBL] [Abstract][Full Text] [Related]
4. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
[TBL] [Abstract][Full Text] [Related]
5. Adriamycin analogues. Novel anomeric ribofuranoside analogues of daunorubicin.
Israel M; Airey JE; Murray RJ; Gillard JW
J Med Chem; 1982 Jan; 25(1):28-31. PubMed ID: 7086818
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumour activity of new daunorubicin and adriamycin analogues.
Arcamone F; Bernardi L; Patelli B; Giardino P; Di Marco A; Casazza AM; Soranzo C; Pratesi G
Experientia; 1978 Oct; 34(10):1255-7. PubMed ID: 570116
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
Stefańska B; Dzieduszycka M; Bontemps-Gracz M; Borowski E; Martelli S
J Antibiot (Tokyo); 1988 Feb; 41(2):193-8. PubMed ID: 3356607
[TBL] [Abstract][Full Text] [Related]
8. Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells.
Capranico G; Soranzo C; Zunino F
Cancer Res; 1986 Nov; 46(11):5499-503. PubMed ID: 3463414
[TBL] [Abstract][Full Text] [Related]
9. [Models of preclinical studies of anthracyclines].
Fizames C
Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
[TBL] [Abstract][Full Text] [Related]
10. Effect of various substitutions in positions 1, 2, 3, and 4 of 4-demethoxydaunorubicin and 4-demethoxyadriamycin.
Di Marco A; Casazza AM; Soranzo C; Pratesi G
Cancer Chemother Pharmacol; 1978; 1(4):249-54. PubMed ID: 750112
[TBL] [Abstract][Full Text] [Related]
11. New anthracycline glycosides obtained by the nitrous acid deamination of daunorubicin, doxorubicin and their configurational analogues.
Cassinelli G; Ballabio M; Arcamone F; Casazza AM; Podesta' A
J Antibiot (Tokyo); 1985 Jul; 38(7):856-67. PubMed ID: 3861603
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of 7-O-[2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-alpha-L-talopyranosyl]- daunomycinone and -adriamycinone.
Nakai K; Takagi Y; Tsuchiya T
Carbohydr Res; 1999 Mar; 316(1-4):47-57. PubMed ID: 10420587
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity of 5'-demethyl-5'-trifluoromethyl-daunorubicin and -doxorubicin.
Nakai K; Takagi Y; Ogawa S; Tsuchiya T
Carbohydr Res; 1999 Jul; 320(1-2):8-18. PubMed ID: 10515060
[TBL] [Abstract][Full Text] [Related]
14. 3'-Hydroxyesorubicin halogenated at C-2'.
Priebe W; Neamati N; Perez-soler R
J Antibiot (Tokyo); 1992 Mar; 45(3):386-93. PubMed ID: 1577666
[TBL] [Abstract][Full Text] [Related]
15. Enhanced antitumor properties of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin.
Mosher CW; Wu HY; Fujiwara AN; Acton EM
J Med Chem; 1982 Jan; 25(1):18-24. PubMed ID: 7086816
[TBL] [Abstract][Full Text] [Related]
16. Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moiety.
Di Marco A; Casazza AM; Dasdia T; Necco A; Pratesi G; Rivolta P; Velcich A; Zaccara A; Zunino F
Chem Biol Interact; 1977 Dec; 19(3):291-302. PubMed ID: 597963
[TBL] [Abstract][Full Text] [Related]
17. Adriamycin analogues. Preparation and antitumor evaluation of 7-O-(beta-D-glucosaminyl)daunomycinone and 7-O-(beta-D-glucosaminyl)adriamycinone and their N-trifluoroacetyl derivatives.
Israel M; Murray RJ
J Med Chem; 1982 Jan; 25(1):24-8. PubMed ID: 7086817
[TBL] [Abstract][Full Text] [Related]
18. Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells.
Ganapathi R; Grabowski D; Schmidt H; Seshadri R; Israel M
Biochem Biophys Res Commun; 1985 Sep; 131(2):912-9. PubMed ID: 2932108
[TBL] [Abstract][Full Text] [Related]
19. Adriamycin analogues. 2. Synthesis of 13-deoxyanthracyclines.
Smith TH; Fujiwara AN; Henry DW
J Med Chem; 1978 Mar; 21(3):280-3. PubMed ID: 628003
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory activity of four demethoxy fluorinated anthracycline analogs against five human-tumor cell lines.
Horton D; Khare A
Bioorg Med Chem Lett; 2010 Nov; 20(21):6179-81. PubMed ID: 20850305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
